Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Jul 27, 2022; 14(7): 656-669
Published online Jul 27, 2022. doi: 10.4240/wjgs.v14.i7.656
Published online Jul 27, 2022. doi: 10.4240/wjgs.v14.i7.656
Table 1 Basic characteristics of adult patients with allied disorders of Hirschsprung’s disease
| Basic characteristic | Data (n = 53) |
| Age (yr) | 48.8 ± 14.3 |
| Onset age (yr) | 42.8 ± 17.9 |
| Hospitalization days | 14.0 (10.0, 21.0) |
| Sex (n, %) | |
| Male | 18 (34.0) |
| Female | 35 (66.0) |
| Blood type (n, %) | |
| A | 10 (18.9) |
| B | 17 (32.1) |
| AB | 6 (11.3) |
| O | 19 (35.8) |
| Unknown | 1 (1.9) |
| All surgical history (n, %) | 25 (47.2) |
| Abdominal | 18 (34.2) |
| Non-abdominal | 7 (13.2) |
| Smoking (n, %) | |
| Yes | 5 (9.4) |
| No | 48 (90.6) |
| Drinking (n, %) | |
| Yes | 2 (3.8) |
| No | 51 (96.2) |
| Enteroscopy (n, %) | |
| Abnormality | 5 (9.4) |
| Non-abnormality | 11 (20.8) |
| Unexamined | 37 (69.8) |
| Barium enema (n, %) | |
| Intestinal dilation | 17 (32.1) |
| No abnormality | 5 (9.4) |
| Unexamined | 31 (58.5) |
Table 2 Blood test indices between allied disorders of Hirschsprung’s disease (case group) versus irritable bowel syndrome (control group) patients
| Parameter | Case group (n = 53) | Control group (n = 58) | P value |
| Age (yr) | 48.8 ± 14.3 | 49.8 ± 14.5 | 0.715 |
| Male (n, %) | 18 (34.0%) | 24 (41.4%) | 0.421 |
| Body mass index (kg/m2) | 20.2 (18.8, 21.6) | 22.6 (20.3, 25.0) | < 0.001c |
| White blood cells (× 109/L) | 5.4 (3.9, 6.8) | 5.4 (4.7, 6.4) | 0.512 |
| Neutrocyte proportion (%) | 61.0 ± 14.5 | 57.9 ± 10.0 | 0.190 |
| Lymphocyte proportion (%) | 30.0 ± 14.2 | 32.1 ± 9.5 | 0.371 |
| Red blood cells (× 1012/L) | 4.3 (4.0, 4.6) | 4.4 (4.0, 4.8) | 0.064 |
| Hemoglobin (g/L) | 128.5 ± 16.2 | 133.9 ± 21.9 | 0.141 |
| Platelet count (× 109/L) | 214.0 (171.0, 260.5) | 213.0 (161.8, 245.0) | 0.445 |
| Total protein (g/L) | 64.2 ± 9.6 | 69.3 ± 5.7 | 0.001b |
| Albumin (g/L) | 41.2 ± 7.1 | 44.1 ± 4.3 | 0.014a |
| Alanine aminotransferase (U/L) | 13.0 (9.5, 19.0) | 17.0 (10.8, 27.3) | 0.061 |
| Aspartate aminotransferase (U/L) | 14.0 (17.0, 21.5) | 19.0 (15.0, 26.0) | 0.090 |
| Cholinesterase (U/L) | 6331.0 (4900.5, 7575.0) | 7534.0 (6877.8, 9216.8) | < 0.001c |
| Creatinine (μmol/L) | 61.0 ± 14.2 | 67.2 ± 13.3 | 0.018a |
| Triglyceride (mmol/L) | 1.0 (0.7, 1.3) | 1.2 (0.9, 1.7) | 0.013a |
| Total cholesterol (mmol/L) | 3.9 ± 1.0 | 4.3 ± 0.9 | 0.013a |
| Fasting blood glucose (mmol/L) | 4.8 (4.3, 5.8) | 4.8 (4.0, 5.2) | 0.225 |
| Serum potassium (mmol/L) | 4.0 ± 0.5 | 4.1 ± 0.4 | 0.139 |
| Serum sodium (mmol/L) | 141.0 (139.0, 142.0) | 142.0 (140.0, 143.0) | 0.011a |
| Blood chlorine (mmol/L) | 103.0 (101.0, 105.0) | 104.0 (103.0, 106.0) | 0.009b |
| Blood calcium (mmol/L) | 2.2 (2.1, 2.3) | 2.2 (2.1, 2.3) | 0.254 |
| Serum phosphorus (mmol/L) | 1.1 ± 0.3 | 1.2 ± 0.2 | 0.327 |
Table 3 Prediction of the allied disorders of Hirschsprung’s disease vs irritable bowel syndrome based on multivariate logistic regression model
| Value | P value | OR | 95%CI |
| Body mass index | 0.013 | 0.786 | 0.649-0.951 |
| Cholinesterase, per 1000 units | 0.008 | 0.693 | 0.527-0.910 |
| Blood chlorine | 0.022 | 0.816 | 0.686-0.971 |
- Citation: Jiang S, Song CY, Feng MX, Lu YQ. Adult patients with allied disorders of Hirschsprung’s disease in emergency department: An 11-year retrospective study. World J Gastrointest Surg 2022; 14(7): 656-669
- URL: https://www.wjgnet.com/1948-9366/full/v14/i7/656.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i7.656
